Despite our best efforts, sometimes errors make it into the final newsletter. We’d like to thank Dr. Jonathan Gamze for pointing out the following errors in Volume 3, Number 5 (Substance Abuse, November 2012): 1) Antabuse was listed as available as a 200 mg pill; in fact it is available in a 250 mg pill; 2) Suboxone is a combination of buprenorphine and naloxone, not buprenorphine and naltrexone, as erroneously stated in the report. Our apologies.
The transition to college can be challenging for any adolescent, but when an adolescent has psychological conditions, or they're dealing with other mental health concerns, it is...
